Page last updated: 2024-10-26

diethylcarbamazine and Parasitic Skin Diseases

diethylcarbamazine has been researched along with Parasitic Skin Diseases in 17 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Research Excerpts

ExcerptRelevanceReference
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial."9.05Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985)
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial."5.05Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985)
"In persons with onchocerciasis, topical application of the anthelminthic diethylcarbamazine (DEC) induces clinical and histologic responses similar to acute papular onchodermatitis, including recruitment of eosinophils to the skin."3.70Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine. ( Boatin, BA; Gilles, AA; Higgins, AW; Pearlman, E; Toé, L; Unnasch, TR, 1999)
"Retreatment with diethylcarbamazine again caused pruritus, but this was tolerated as were subsequent treatments."1.26Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States. ( Beaver, PC; Bray, DM; Grannis, FW; Palomar, JM, 1976)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-199010 (58.82)18.7374
1990's3 (17.65)18.2507
2000's2 (11.76)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Senanayake, MP1
Infaq, ML1
Adikaram, SG1
Udagama, PV1
Gaur, MK1
Goel, A1
Gupta, S1
Sbeity, ZH1
Jaksche, A1
Martin, S1
Loeffler, KU1
Cahill, KM1
Vermeer, BJ1
van der Kaay, HJ1
Rozenman, D1
Kremer, M1
Zuckerman, F1
Krautheim, H1
Edungbola, LD1
Takeuchi, T1
Pearlman, E1
Toé, L1
Boatin, BA1
Gilles, AA1
Higgins, AW1
Unnasch, TR1
Goljan, J1
Nahorski, W1
Tomaszewski, R1
Felczak-Korzybska, I1
Górski, J1
Connor, DH1
Palomar, JM1
Bray, DM1
Grannis, FW1
Beaver, PC1
Bergner, T1
Löscher, T1
Barutzki, D1
Przybilla, B1
Albiez, EJ1
Newland, HS2
White, AT2
Kaiser, A1
Greene, BM2
Taylor, HR2
Büttner, DW1
Cupp, EW1
Murphy, RP1
Aziz, MA1
Schulz-Key, H1
D'Anna, SA1
Goldschmidt, LP1
Duke, BO1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis[NCT04188301]Phase 2154 participants (Actual)Interventional2019-12-06Completed
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis[NCT06070116]Phase 2300 participants (Anticipated)Interventional2024-01-15Not yet recruiting
Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis[NCT03517462]231 participants (Actual)Interventional2018-08-06Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Effectiveness of Killing Adult Female Worms

The effectiveness of three treatment regimens for killing adult female O. volvulus worms based on the percentage of all adult female worms in nodules that are alive 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment

InterventionFemale worms in nodule (Count of Units)
IVM + ALB127
IDA x 1 Dose142
IDA x 3 Doses159

Percentage of Worms Killed Across Study Arms

The effect of three treatment regimens for killing adult female O. volvulus worms will be compared based on the percentage of all adult female worms in nodules that are alive with embryos in the uterus 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.

InterventionFemale worms in nodules (Count of Units)
IVM + ALB127
IDA x 1 Dose142
IDA x 3 Doses159

Percentage of Worms Sterilized Across Study Arms

The effect of three treatment regimens for sterilizing adult female O. volvulus worms will be compared based on the percentage of all adult female worms that are fertile in the nodules 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.

InterventionFemale worms with intact uterus (Count of Units)
IVM + ALB41
IDA x 1 Dose40
IDA x 3 Doses34

Rates of Ocular Adverse Events (Any Grade) by Treatment Group

Rates of ocular adverse events of any grade within 3 months will be compared by treatment group. (NCT04188301)
Timeframe: within 3 months of treatment with IDA

InterventionParticipants (Count of Participants)
IVM + ALB4
IDA x 1 Dose4
IDA x 3 Doses3

Rates of SAEs by Treatment Group in Those With Intraocular Microfilariae Just Prior to Treatment With IDA

Rates of adverse events grade 3 or higher that occur within 7 days of treatment in the subset of participants who have intraocular microfilariae just prior to treatment with IDA will be compared by treatment group. (NCT04188301)
Timeframe: within 7 days following end of treatment

InterventionParticipants (Count of Participants)
IVM + ALB0
IDA x 1 Dose0
IDA x 3 Doses0

Rates of Severe Adverse Events (SAEs) Across Study Arms

Rates of severe adverse events (grade 3 or higher) following 1-day or 3-day triple drug treatment will be compared against those of the comparator regimen of 1 day of IVM/ALB. (NCT04188301)
Timeframe: Within 7 days following end of treatment

InterventionParticipants (Count of Participants)
IVM + ALB0
IDA x 1 Dose0
IDA x 3 Doses0

Effectiveness for Preventing Reappearance of Microfilariae in the Skin by Skin Snips

The effectiveness of three treatment regimens for preventing reappearance of microfilariae in the skin as determined by skin snips at 12 and 18 months after treatment will be compared by treatment arm. Measured by the presence of microfilariae in skin snips. (NCT04188301)
Timeframe: Baseline, 12 months, and 18 months following treatment

,,
InterventionCount of microfilarae+ participants (Number)
BaselineMonth 12Month 18
IDA x 1 Dose62115
IDA x 3 Doses02117
IVM + ALB72320

Effectiveness of Clearing Microfilariae From Skin by Skin Snips

The effectiveness of three treatment regimens for complete clearance of microfilariae from the skin as determined by skin snips at 3, 12, and 18 months after treatment with IDA will be compared by treatment arm. (NCT04188301)
Timeframe: Baseline, 3 months, 12 months, & 18 months following treatment.

,,
InterventionCount of Skin Microfilaria (Geometric Mean)
BaselineMonth 3Month 12Month 18
IDA x 1 Dose1.732.59.0
IDA x 3 DosesNA2.14.78.6
IVM + ALB3.11.94.97.0

Reviews

1 review available for diethylcarbamazine and Parasitic Skin Diseases

ArticleYear
[Onchocerciasis].
    Ryoikibetsu shokogun shirizu, 1999, Issue:24 Pt 2

    Topics: Animals; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Filaricides; Humans; Ive

1999

Trials

2 trials available for diethylcarbamazine and Parasitic Skin Diseases

ArticleYear
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1988, Volume: 39, Issue:1

    Topics: Adult; Animals; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-B

1988
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985

Other Studies

14 other studies available for diethylcarbamazine and Parasitic Skin Diseases

ArticleYear
Ocular and subcutaneous dirofilariasis in a Sri Lankan infant: an environmental hazard caused by dogs and mosquitoes.
    Paediatrics and international child health, 2013, Volume: 33, Issue:2

    Topics: Animals; Diethylcarbamazine; Dirofilaria repens; Dirofilariasis; Eye Diseases; Filaricides; Humans;

2013
An elephantine problem.
    European journal of internal medicine, 2017, Volume: 44

    Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Male; Skin Disease

2017
Loa loa macrofilariasis in the eyelid: case report of the first periocular subcutaneous manifestation in Germany.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:7

    Topics: Adult; Africa; Animals; Diethylcarbamazine; Eye Infections, Parasitic; Eyelid Diseases; Female; Fila

2006
Bancroftian filarial nodule. Report of a case.
    The American journal of tropical medicine and hygiene, 1967, Volume: 16, Issue:5

    Topics: Adult; Complement Fixation Tests; Diethylcarbamazine; Filariasis; Granuloma; Humans; Male; Skin Dise

1967
Loiasis: a case report.
    Acta dermato-venereologica, 1982, Volume: 62, Issue:1

    Topics: Adult; Diethylcarbamazine; Eyelid Diseases; Female; Filariasis; Humans; Loiasis; Netherlands; Nigeri

1982
Onchocerciasis in Israel.
    Archives of dermatology, 1984, Volume: 120, Issue:4

    Topics: Adolescent; Diagnosis, Differential; Diethylcarbamazine; Ethiopia; Eye Diseases; Humans; Israel; Mal

1984
[Loaiasis. Clinical aspects and therapy in the field of dermatology].
    Die Medizinische Welt, 1982, Jun-11, Volume: 33, Issue:23

    Topics: Adult; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Female; Filariasis; Humans

1982
Prevalence of onchocerciasis in Ile-Ire District, (Ifelodun), Kwara State, Nigeria.
    Tropical and geographical medicine, 1982, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Blindness; Child; Child, Preschool; Diethylcarbamazine; Female; Humans; Inf

1982
Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:4

    Topics: Administration, Topical; Adolescent; Animals; Antiparasitic Agents; Chemokine CCL11; Chemokines, CC;

1999
Diagnosing and treatment of skin filariases based on own observations.
    International maritime health, 2000, Volume: 51, Issue:1-4

    Topics: Adolescent; Adult; Antiparasitic Agents; Diethylcarbamazine; Female; Filariasis; Filaricides; Humans

2000
Onchocercal dermatitis-current concepts of pathogenesis.
    The Southeast Asian journal of tropical medicine and public health, 1978, Volume: 9, Issue:2

    Topics: Dermatitis; Diethylcarbamazine; Humans; Onchocerciasis; Skin; Skin Diseases, Parasitic

1978
Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States.
    Archives of surgery (Chicago, Ill. : 1960), 1976, Volume: 111, Issue:8

    Topics: Adult; Antiparasitic Agents; Diethylcarbamazine; Female; Humans; Onchocerciasis; Skin; Skin Diseases

1976
[Subcutaneous dirofilariasis: infection with Dirofilaria repens].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1990, Volume: 41, Issue:5

    Topics: Animals; Antiparasitic Agents; Diethylcarbamazine; Dirofilaria; Dirofilariasis; Facial Dermatoses; F

1990
Onchocerciasis.
    British medical journal, 1968, Nov-02, Volume: 4, Issue:5626

    Topics: Africa; Central America; Diagnosis, Differential; Diethylcarbamazine; Eye Manifestations; Humans; On

1968